Preloader Close
M E D I S U R E

Molecular and Infectious Disease Testing (PCR)

Infectious Disease Detection

Our molecular infectious disease testing identifies pathogens by detecting genetic material directly from clinical specimens. This approach delivers higher sensitivity and specificity than traditional culture-based methods and enables rapid diagnosis across a wide range of clinical scenarios.
Testing supports detection of viral, bacterial, and fungal pathogens from respiratory, urine, wound, blood, and tissue samples. Molecular diagnostics are particularly valuable for patients with prior antibiotic exposure, severe infections, or atypical clinical presentations.

Urinary Tract Infection Testing

Urinary tract infection testing provides sensitive detection of bacterial pathogens responsible for UTIs, including cases that may be missed by standard urine culture. Molecular testing allows simultaneous detection of multiple uropathogens and can identify resistance markers when clinically indicated.

Suitable Candidates Include:

  • Patients with recurrent or persistent urinary symptoms
  • Individuals with prior antibiotic treatment and unresolved infection
  • Pregnant patients requiring accurate diagnosis
  • Patients with complicated or chronic urinary tract conditions
Rapid and accurate results support targeted therapy and help reduce unnecessary antibiotic use.
View Brochure

Respiratory Pathogen Panel

The respiratory pathogen panel is a multiplex molecular test designed to identify viral and bacterial causes of upper and lower respiratory tract infections from a single specimen.

Suitable Candidates:

  • Patients with acute respiratory symptoms
  • Individuals with severe or worsening respiratory illness
  • Immunocompromised patients
  • Patients during seasonal respiratory outbreaks
Results support differentiation between viral and bacterial infections, guide isolation decisions, and inform appropriate treatment.
View Brochure

Wound Infection Testing

Wound infection testing enables precise identification of bacterial, fungal, and select viral pathogens present in acute and chronic wounds. Molecular diagnostics improve detection in cases where traditional cultures may be limited due to slow growth or prior antimicrobial use.

Suitable Candidates:

  • Patients with non-healing or chronic wounds
  • Post-surgical patients with suspected infection
  • Burn or traumatic wound cases
  • Patients with prior negative or inconclusive cultures
Accurate pathogen identification supports effective wound management and treatment planning.
View Brochure

Nail Infection Testing

Nail infection testing provides accurate detection of fungal and bacterial pathogens responsible for nail disorders, including onychomycosis and chronic nail bed infections.

Suitable Candidates:

  • Patients with suspected fungal nail infection
  • Individuals with recurrent or treatment-resistant nail disease
  • Patients with atypical nail presentations
  • Diabetic or immunocompromised patients
Molecular testing improves diagnostic confidence and supports appropriate antifungal or antimicrobial therapy.
View Brochure

Eye Infection Testing

Eye infection testing enables rapid identification of infectious agents causing conjunctivitis, keratitis, and other ocular infections. Early detection is critical to prevent complications and preserve vision.

Suitable Candidates:

  • Patients with acute eye pain, redness, or discharge
  • Contact lens wearers with suspected infection
  • Immunocompromised patients
  • Patients with severe or rapidly progressing ocular symptoms
Testing supports ophthalmology practices and urgent clinical care settings.
View Brochure

ENT Infection Testing

ENT infection testing supports diagnosis of infections affecting the ear, nose, and throat, including sinusitis, otitis media, and pharyngitis. Molecular diagnostics provide faster and more accurate pathogen detection than traditional methods.

Suitable Candidates:

  • Patients with recurrent sinus or ear infections
  • Individuals with chronic ENT symptoms
  • Patients unresponsive to empiric antibiotic therapy
  • Pediatric and adult patients with persistent ENT infections
Results help guide targeted treatment and reduce inappropriate antibiotic use.
View Brochure

Sexually Transmitted Diseases Testing

STD testing offers sensitive and specific detection of sexually transmitted infections using molecular diagnostics. Testing can identify infections from urine or swab samples, including asymptomatic cases.

Suitable Candidates:

  • Sexually active individuals undergoing routine screening
  • Patients with symptoms of sexually transmitted infections
  • High-risk populations
  • Patients with known exposure to STDs
Early and accurate detection supports timely treatment and transmission prevention.
View Brochure

COVID Testing

COVID testing remains the gold standard for detection of SARS-CoV-2 infection. Molecular testing offers high sensitivity and specificity for diagnostic and screening purposes.

Suitable Candidates:

  • Symptomatic individuals
  • Patients with known exposure
  • Pre-procedural or pre-admission screening
  • Travel or workplace testing requirements
Testing supports infection control and clinical decision-making.
View Brochure

Antimicrobial Resistance Gene Detection

Antimicrobial resistance gene detection identifies genetic markers associated with antibiotic resistance in bacterial pathogens. This testing supports antimicrobial stewardship and targeted therapy selection.

Suitable Candidates:

  • Patients with recurrent or persistent infections
  • Hospitalized patients with severe infections
  • Cases with treatment failure
  • Patients with known multidrug-resistant organisms
Understanding resistance patterns improves therapeutic outcomes.
View Brochure

Bacterial, Viral, and Fungal Pathogen Identification

Comprehensive pathogen identification using molecular diagnostics enables rapid and accurate detection of infectious agents from clinical samples when traditional testing is inconclusive.

Suitable Candidates:

  • Patients with complex or atypical infections
  • Immunocompromised individuals
  • Severe or systemic infections
  • Cases requiring rapid diagnostic clarity
Multiplex molecular panels support timely clinical decisions and improved patient care.
View Brochure